Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis.

Multiple counterregulatory mechanisms have been identified in B-cell precursors that operate to regulate cell survival and growth, thereby ensuring the orderly development and differentiation of B-cells. Inappropriate apoptosis may underlie the pathogenesis of immunodeficiencies, as well as pathogenesis and drug/radiation resistance of human leukemias and lymphomas, which makes control of apoptosis an important potential target for therapeutic interventions. Therefore, identification of the molecular regulators of apoptosis is an area of intense investigation. Bruton's tyrosine kinase (BTK) is the first tyrosine kinase to be identified as a dual-function regulator of apoptosis, which promotes radiation-induced apoptosis but inhibits Fas-activated apoptosis in B-cells. BTK functions in a pro-apoptotic manner when B-cells are exposed to reactive oxygen intermediates, at least in part, by down-regulating the anti-apoptotic activity of STAT-3 transcription factor. In contrast, BTK associates with the death receptor Fas and impairs its interaction with Fas-associated protein with death domain (FADD), which is essential for the recruitment and activation of FLICE by Fas during the apoptotic signal, thereby preventing the assembly of a pro-apoptotic death inducing signaling complex (DISC) after Fas-ligation. The identification of BTK as a dual-function regulator of apoptosis will significantly increase our understanding of both the biological processes involved in programmed cell death and the diseases associated with dysregulation of apoptosis. New agents with BTK-modulatory activity may have clinical potential in the treatment of B-cell malignancies (in particular acute lymphoblastic leukemia, the most common form of childhood cancer), as well as B-cell immunodeficiencies.

[1]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[2]  D. Baltimore,et al.  Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[4]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[5]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[6]  T. Hirano,et al.  Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK , 1997, Oncogene.

[7]  J. Ihle.  Janus kinases in cytokine signalling. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[8]  John D Lambris,et al.  Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. , 1994, Journal of immunology.

[9]  B. Williams,et al.  Roles of Protein-tyrosine Phosphatases in Stat1α-mediated Cell Signaling (*) , 1995, The Journal of Biological Chemistry.

[10]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[11]  Ornella Parolini,et al.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.

[12]  M. Grompe,et al.  Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. , 1997, Blood.

[13]  J. Fargnoli,et al.  Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase , 1995, Molecular and cellular biology.

[14]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[15]  D. Bentley,et al.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.

[16]  G. Schieven,et al.  Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Renauld,et al.  A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9 , 1996, Molecular and cellular biology.

[18]  M. Pinkoski,et al.  A Physical Interaction between the Cell Death Protein Fas and the Tyrosine Kinase p59(*) , 1996, The Journal of Biological Chemistry.

[19]  J. Kehrl,et al.  Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites. , 1996, Blood.

[20]  K. Schulze-Osthoff,et al.  Divergent signalling via APO‐1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. , 1994, The EMBO journal.

[21]  D J Rawlings,et al.  Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. , 1993, Science.

[22]  A. Lichtenstein,et al.  Interleukin-6 inhibits apoptosis of malignant plasma cells. , 1995, Cellular immunology.

[23]  Erwin G. Van Meir,et al.  IL-6 stimulates growth and inhibits constitutive, protein synthesis-independent apoptosis of murine B-cell hybridoma 7TD1. , 1994, Cellular immunology.

[24]  D. Levy.  The house that Jak/Stat built. , 1997, Cytokine & growth factor reviews.

[25]  J. Ihle,et al.  Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis , 1993, Molecular and cellular biology.

[26]  A. Burkhardt,et al.  Role of hydroxyl radicals in radiation-induced activation of lyn tyrosine kinase in human B-cell precursors. , 1996, Leukemia & lymphoma.

[27]  E. Gulbins,et al.  Activation of Src‐family tyrosine kinases during Fas‐induced apoptosis , 1996, Journal of leukocyte biology.

[28]  T. Kurosaki,et al.  A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2 , 1996, The Journal of experimental medicine.

[29]  O. Witte,et al.  Bruton's Tyrosine Kinase is a Key Regulator in B‐Cell Development , 1994, Immunological reviews.

[30]  K. Schulze-Osthoff,et al.  Cell nucleus and DNA fragmentation are not required for apoptosis , 1994, The Journal of cell biology.

[31]  J. Camonis,et al.  A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[32]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[33]  D. Newmeyer,et al.  Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria , 1994, Cell.

[34]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[35]  J. Darnell,et al.  A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. , 1993, Science.

[36]  John Calvin Reed,et al.  FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.

[37]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[38]  H. Koizumi,et al.  Rescue by cytokines of apoptotic cell death induced by IL‐2 deprivation of human antigen‐specific T cell clones , 1997, Clinical and experimental immunology.

[39]  H. Wortis,et al.  An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Goud.  Rapid communication: effect of irradiation on lymphocyte proliferation and differentiation: potential of IL-6 in augmenting antibody responses in cultures of murine spleen cells. , 1995, International journal of radiation biology.

[41]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[42]  N. Copeland,et al.  A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors. , 1995, The EMBO journal.

[43]  G. Evan,et al.  A License to Kill , 1996, Cell.

[44]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[45]  D. Green,et al.  Cell‐free reconstitution of Fas‐, UV radiation‐ and ceramide‐induced apoptosis. , 1995, The EMBO journal.

[46]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain , 1996, Nature.

[47]  J. Ward,et al.  DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. , 1988, Progress in nucleic acid research and molecular biology.

[48]  N. Miyasaka,et al.  An Epidermal Growth Factor Receptor/Jak2 Tyrosine Kinase Domain Chimera Induces Tyrosine Phosphorylation of Stat5 and Transduces a Growth Signal in Hematopoietic Cells* , 1996, The Journal of Biological Chemistry.

[49]  T. Kurosaki,et al.  Molecular mechanisms in B cell antigen receptor signaling. , 1997, Current opinion in immunology.

[50]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[51]  S. Korsmeyer.  Regulators of cell death. , 1995, Trends in genetics : TIG.

[52]  T. Hirano,et al.  Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. , 1995, Blood.

[53]  P Jay,et al.  Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.

[54]  V. Fadok,et al.  Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.

[55]  J. Darnell,et al.  Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway , 1995, Science.

[56]  T. Hirano,et al.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.

[57]  M. Heim,et al.  The Jak–STAT pathway: specific signal transduction from the cell membrane to the nucleus , 1996, European journal of clinical investigation.

[58]  J. Darnell,et al.  A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. , 1995, Genes & development.

[59]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[60]  W. Fiers,et al.  Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis , 1995, Nature.

[61]  C. I. Smith,et al.  Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members. , 1996, Oncogene.

[62]  L. Tuel-ahlgren,et al.  Engagement of the CD19 receptor on human B-lineage leukemia cells activates LCK tyrosine kinase and facilitates radiation-induced apoptosis. , 1993, Radiation research.

[63]  A. Akhand,et al.  Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation. , 1996, Oncogene.

[64]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[65]  G. Salvesen,et al.  FLICE Induced Apoptosis in a Cell-free System , 1997, The Journal of Biological Chemistry.

[66]  R. Lefkowitz,et al.  Binding of G protein beta gamma-subunits to pleckstrin homology domains. , 1994, The Journal of biological chemistry.

[67]  H. Folch,et al.  Radiation induced membrane changes and programmed cell death: possible interrelationships. , 1994, Scanning microscopy.

[68]  M. Caligiuri,et al.  Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. , 1997, Blood.

[69]  Y. Lazebnik,et al.  Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis , 1993, The Journal of cell biology.

[70]  M. Saraste,et al.  Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X‐linked agammaglobulinaemia , 1997, The EMBO journal.

[71]  F. Uckun,et al.  Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery. , 1999, Leukemia & lymphoma.

[72]  F. Alt,et al.  Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  G. Linette,et al.  Differentiation and cell death: lessons from the immune system. , 1994, Current opinion in cell biology.

[74]  O. Witte,et al.  Regulation of Btk by Src family tyrosine kinases , 1996, Molecular and cellular biology.

[75]  J. Darnell,et al.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors , 1995, Science.

[76]  T. Kurosaki,et al.  BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells , 1996, Science.

[77]  G. Stark,et al.  Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[79]  Seamus J. Martin,et al.  Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.

[80]  Guy S. Salvesen,et al.  X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[81]  B. Williams,et al.  Interacting pathways of interferon signaling. , 1997, Seminars in oncology.

[82]  R. Schreiber,et al.  Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. , 1995, Immunity.

[83]  M. Conley,et al.  Transcriptional Regulatory Elements Within the First Intron of Bruton's Tyrosine Kinase , 1998 .

[84]  A. Kuramoto,et al.  Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. , 1995, Blood.